The Defense Health Agency awarded a blanket purchase agreement to Prolacta Bioscience, Inc. to provide various human milk-based products in support of neonatal patients. Under multiple firm fixed price call contracts issued against this agreement from October 2022 through September 2027, Prolacta will deliver breastmilk, breastmilk fortification products, and supplementation items to military medical treatment facilities. Places of performance include Bassett, California and Tripler Army Medical Center in Hawaii. Contract values range from approximately $13,000 to $1.75 million.
The milk-based products are intended to support premature and critically ill newborn infants receiving treatment in neonatal intensive care units. As the leading provider of human milk-based nutritional therapies and the only awardee, Prolacta is well positioned to meet the specialized needs of the pediatric patient population served by the Defense Health Agency and its medical facilities. The agency utilizes these types of prime vendor agreements to streamline delivery of important supplies that enhance healthcare support for military service members, veterans, and their families.
Generated 1/4/24, 4:42 PM